Aptevo Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Aptevo Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Aptevo Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $53.2M, a 8.36% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $53.2M +$4.1M +8.36% Dec 31, 2023 10-K 2024-03-05
Q4 2022 $49.1M -$1.13M -2.25% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $50.2M +$5.95M +13.4% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $44.3M +$4.4M +11% Dec 31, 2020 10-K 2022-03-24
Q4 2019 $39.9M +$9.59M +31.6% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $30.3M +$13.2M +76.8% Dec 31, 2018 10-K 2020-03-25
Q4 2017 $17.1M -$12.7M -42.5% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $29.8M -$105M -77.8% Dec 31, 2016 10-K 2018-03-13
Q4 2015 $134M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.